Leadership as the foundation of a strong pharmaceutical site: Why management, culture and attitude determine resilience.
Why leadership is more than management.
The pharmaceutical industry is under massive pressure to change. Regulatory requirements, technological innovations and economic conditions are continuously evolving. Yet while investments in infrastructure and technology frequently take centre stage, one decisive factor is often underestimated: leadership and corporate culture.
In this episode of the Inside Complex Pharma podcast, Christoph Reinwald, CEO of Complex Pharmaceuticals, discusses why leadership is not merely an internal management task, but a strategic location factor for Austria as a pharmaceutical site.
Leadership as a location factor — not a management style
Christoph Reinwald makes it clear early on that leadership, for him, goes far beyond classical management models. Competitiveness is not created solely through subsidies, regulation or infrastructure, but above all through people, attitude and leadership.
“Leadership is for me the bridge between technological excellence, regulatory security and human motivation.”
Leadership in this context means creating the conditions in which highly qualified employees can operate over the long term — with clarity, trust and responsibility. A site remains competitive only when people can not only contribute, but also develop themselves and identify with the company.
Why culture creates more value than technology
Technology and infrastructure are necessary — but they do not guarantee sustainable value creation. In the pharmaceutical industry, it is ultimately not machines but people who decide on quality, compliance or supply security.
“Quality is not created by processes alone, but by attitude.”
Christoph Reinwald emphasises that aspects such as a constructive approach to error management, quality awareness and regulatory diligence cannot be automated. Technology can be copied — culture cannot. Therein lies the long-term competitive advantage.
“People are not resources, but strategic assets.”
Companies that invest purposefully in attitude, responsibility and development secure not only their own future viability, but also strengthen the pharmaceutical site as a whole.
Modern leadership: Orientation rather than control
Compared to the past, the role of leaders has fundamentally changed. While control and micromanagement previously dominated, today the focus is on orientation, transparency and trust.
“Leaders today need to provide fewer answers and ask the right questions more consistently.”
Christoph Reinwald draws a clear distinction from micromanagement. In knowledge-intensive, highly regulated areas, detailed control is not only inefficient, but counterproductive.
“Micromanagement is an expression of mistrust and prevents individual accountability.”
Modern leadership means:
- creating space for decisions
- deploying strengths purposefully
- allowing dialogue and feedback
- and taking criticism seriously.
The most expensive phrase in any company, he notes, is: ‘We’ve always done it this way.’
Leadership requires maturity, listening and leading by example
A key point in the discussion is the personal maturity of leaders. Allowing criticism, reflecting on oneself and listening are more important today than ever.
“Those who wish to provide orientation must embody it themselves.”
Decisions made under pressure shape an organisation more strongly than any strategy. Leadership is not demonstrated through perfection, but in how one deals with mistakes, uncertainty and responsibility.
What competencies leadership will need over the next 5–10 years
Looking ahead, Christoph Reinwald describes three core capabilities that leadership must purposefully foster:
- Critical thinking & individual accountability — Employees should understand connections, question them and take responsibility out of genuine conviction.
- Willingness to learn & capacity for change — Learning must become the norm, not an add-on, but part of daily work.
- Sense of purpose & entrepreneurial thinking — People want to understand why their work is relevant — for patients, for supply security and for the location.
“Employees only actively shape progress when purpose and attitude are clearly communicated.”
Employee retention beyond salary and benefits
Stability alone no longer retains talent today. For Christoph Reinwald, long-term retention is created through perspective, purpose and credible leadership.
“The phrase ‘every employee is replaceable’ is not contemporary — and is entrepreneurially dangerous.”
Retention begins where employees experience being effective. When people see that their work makes a difference, loyalty develops — not out of convenience, but out of conviction.
“Employee retention is not a measure, but the result of consistent leadership.”
Personal development as the key to future viability
Professional qualification is for Christoph Reinwald merely the entry ticket. Decisive for long-term success is personal development.
“Knowledge alone does not sustain an organisation.”
Personal development strengthens
- decision-making capability
- capacity for reflection
- communication competence
- sense of responsibility
Transparency plays a central role here. A lack of transparency quickly leads to silo thinking, uncertainty and the loss of internal expertise.
Trust, error culture and compliance — not a contradiction
Precisely because the pharmaceutical industry is highly regulated, trust and individual accountability are indispensable.
“Regulation defines the framework — it does not replace inner attitude.”
An open error culture strengthens quality and compliance. Mistakes should not be sanctioned, but analysed and used for improvement.
“There is nothing reprehensible about making mistakes — it only becomes problematic when one fails to learn from them.”
Leadership in crises: Calm, clarity and responsibility
In situations of pressure, leadership becomes particularly visible. Christoph Reinwald describes his attitude in crises as deliberately calm, transparent and solution-oriented.
“Attitude is more important than perfection.”
Resilience is not created through rallying calls to persevere, but through genuine support and respectful interaction — even under pressure.
Leadership beyond the company
A resilient pharmaceutical site needs leadership that thinks beyond company boundaries. Leadership acts in supply chains, in collaboration with authorities and in society.
“Leadership does not end at the factory gate.”
Reliability, transparency and a sense of purpose strengthen not only the company itself, but also confidence in the entire industry.
Conclusion
Leadership is not a soft factor, but a hard competitive factor. Leadership determines whether quality is lived, knowledge stays in the company and resilience is created. Christoph Reinwald demonstrates convincingly that attitude, culture and responsibility form the foundation for a strong, future-proof pharmaceutical site — in Austria and beyond.
FAQ – Leadership & pharmaceutical site
Why is leadership a location factor in the pharmaceutical industry?
Because leadership determines whether people stay, develop and live quality out of conviction.
What distinguishes modern leadership from classical management?
Orientation, trust and dialogue replace control and micromanagement.
What role does corporate culture play?
Culture cannot be copied and is therefore a central competitive advantage over pure technology.
How does employee retention develop today?
Through purpose, perspective, effectiveness and credible leadership — not through salary alone.
Is an open error culture compatible with compliance?
Yes. It strengthens quality awareness and prevents problems from being concealed.
What makes a resilient pharmaceutical site?
Leadership with attitude, transparency, responsibility and a sense of purpose — internally and externally.